Overview

Gender

male

Adam Hacker joined Autolus as SVP, Regulatory Affairs and Quality on 1 August 2018. Previously he spent a decade at Janssen Pharmaceuticals, where he most recently served as VP, Head of Vaccines and Scientific Innovation Projects, Global Regulatory Affairs. In this role, Adam was responsible for leading regulatory activities across all scientific innovation projects, including collaborating with and overseeing efforts related to the Company’s work on the Microbiome, Disease Interception, Regenerative Medicines & Advanced Therapeutics, and Clinical Trial Innovation/Digital Technology, amongst others. During his tenure at Janssen Pharmaceuticals, he also oversaw all regulatory aspects of the Company’s Ebola vaccine and therapeutic product development, as well as leading hematology and oncology therapeutic areas regulatory and medical affairs functions for the Europe Middle East Africa (EMEA). Adam honed his expertise in regulatory affairs in prior positions, including Head of Oncology, Immunology and Cardiovascular Therapeutic areas at Biogen Idec Ltd. and as Regulatory Advisor and Regulatory Project Manager at GE Healthcare and GlaxoSmithKline Pharmaceuticals, respectively. He earned a PhD in developmental molecular biology from the National Institute of Medical Research, London and holds an undergraduate degree from Oxford University.